Kathi Niffenegger
2019
In 2019, Kathi Niffenegger earned a total compensation of $122.4K as Chief Financial Officer at Edesa Biotech.
Compensation breakdown
| Bonus | $53,750 |
|---|---|
| Salary | $63,604 |
| Other | $5,000 |
| Total | $122,354 |
Niffenegger received $63.6K in salary, accounting for 52% of the total pay in 2019.
Niffenegger also received $53.8K in bonus and $5K in other compensation.
Rankings
In 2019, Kathi Niffenegger's compensation ranked 13,725th out of 13,971 executives tracked by ExecPay. In other words, Niffenegger earned more than 1.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,725 out of 13,971 | 2nd |
Division Manufacturing | 5,601 out of 5,698 | 2nd |
Major group Chemicals And Allied Products | 2,167 out of 2,197 | 1st |
Industry group Drugs | 1,856 out of 1,883 | 1st |
Industry Pharmaceutical Preparations | 1,376 out of 1,395 | 1st |
Source: SEC filing on March 23, 2020.
Niffenegger's colleagues
We found two more compensation records of executives who worked with Kathi Niffenegger at Edesa Biotech in 2019.
News
Edesa Biotech CEO Pardeep Nijhawan's 2023 pay slips 9% to $550K
April 5, 2024
Edesa Biotech CEO Pardeep Nijhawan's 2022 pay falls 54% to $602K
March 28, 2023
Edesa Biotech CEO Pardeep Nijhawan's 2021 pay jumps 221% to $1.3M
April 1, 2022
Edesa Biotech President Michael Brooks' 2020 pay jumps 155% to $529K
March 3, 2021
Edesa Biotech President Michael Brooks' 2019 pay slips 10% to $207K
March 23, 2020